drugset / Trial / NCT00063258
Tarceva Surgery for Resectable Stage IIIA(N2) and IIIB (T4 N2) Non-Small-Cell Lung Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
The goal of this clinical research study is to learn about the safety and effectiveness of OSI-774 when combined with standard chemotherapy (carboplatin and paclitaxel) before surgery in the treatment of non-small cell lung cancer.
Timeline
- Start
- 2003-06
- Primary completion
- 2008-04
- Completion
- 2008-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Erlotinib | Small molecule | 150 mg | Oral |
| Comparator | Carboplatin | Small molecule | 6 unknown | — |
| Comparator | Paclitaxel | Small molecule | 200 mg/m2 | Intravenous |